Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06112132
Other study ID # OVNI
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 15, 2023
Est. completion date September 30, 2024

Study information

Verified date October 2023
Source Association Clinique Thérapeutique Infantile du val de Marne
Contact Levy Corinne
Phone 1 48 85 04 04
Email corinne.levy@activ-france.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is an observational, multicenter and prospective study for surveillance of case of hospitalised children for bronchiolitis associated or not to RSV or other viruses (isolated or associated with RSV)


Description:

The aim of this surveillance is to observe and describe the cases hospitalized for bronchiolitis in the 2023/2024 season in the context of routine immunization with Nirsevimab.


Recruitment information / eligibility

Status Recruiting
Enrollment 2500
Est. completion date September 30, 2024
Est. primary completion date September 30, 2024
Accepts healthy volunteers No
Gender All
Age group 1 Day to 12 Months
Eligibility Inclusion Criteria: - Children under 12 months of age - In one of the 6 study sites - From October 15, 2023 - For acute bronchiolitis defined according to current national and international recommendations - Hospitalized from the pediatric emergency department. Exclusion Criteria: - Refusal to participate by patient relative or legal representative

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France ACTIV Créteil

Sponsors (2)

Lead Sponsor Collaborator
Association Clinique Thérapeutique Infantile du val de Marne Sanofi

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of patients hospitalized for bronchiolitis Assessment of the number of hospitalized bronchiolitis in the context of routine immunization with Nirsevimab 1 year
Secondary Proportion of RSV vs non-RSV associated to bronchiolitis hospitalizations Assessment of proportion of RSV vs non- RSV associated bronchiolitis hospitalizations 1 year
Secondary Proportion of other viruses associated to bronchiolitis hospitalizations. Assessment of the proportion of other viruses (isolated or associated with RSV) associated bronchiolitis hospitalizations 1 year
Secondary Proportion of patients immunized with Nirsevimab among children hospitalized for bronchiolitis Description of immunization status with Nirsevimab of hospitalized patients for bronchiolitis overall (RSV+, RSV-) and other viruses (isolated or associated with RSV) 1 year
Secondary Proportion of demographics and clinical characteristics of patients hospitalized for bronchiolitis overall Description of demographics (including immunization status with Nirsevimab) and clinical characteristics of patients hospitalized for bronchiolitis overall ( RSV+, RSV-) and other viruses (isolated or associated with RSV) 1 year
Secondary Proportion of demographics, clinical and viral characteristics of patients hospitalized for bronchiolitis requiring ventilation support Description of demographics (including immunization status with Nirsevimab), clinical and viral characteristics of patients hospitalized for bronchiolitis requiring ventilation support 1 year
Secondary Length of hospital stay of children with bronchiolitis overall in France Assesment of the duration of hospitalization for bronchiolitis overall (RSV+, RSV-) in France 1 year
Secondary Length of hospital stay of children with bronchiolitis in France according to immunization status with Nirsevimab Assesment of the duration of hospitalization for bronchiolitis according to immunization status with Nirsevimab 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT04989114 - Nasal Bubble Continuous Positive Airway Pressure in Reducing Respiratory Distress in Children With Bronchiolitis N/A
Recruiting NCT06016244 - Safe, Effective and Cost-Effective Oxygen Saturation Targets for Children and Adolescents With Respiratory Distress: a Randomized Controlled Trial N/A
Not yet recruiting NCT05902702 - Isotonic Saline for Children With Bronchiolitis N/A
Recruiting NCT02366715 - Treatment Of Bronchiolitis With Heated Humidified High Flow Nasal Cannula - Prospective And Retrospective Research Phase 3
Terminated NCT02219334 - Comparing Nasal Suction Devices in Children With Bronchiolitis: A Pilot Study N/A
Recruiting NCT01944995 - Work of Breathing in Nasal CPAP Versus High Flow Nasal Prong in Infants With Severe Acute Bronchiolitis N/A
Terminated NCT02834819 - Nebulized 3% Hypertonic Saline vs. Standard of Care in Patients With Bronchiolitis N/A
Terminated NCT01757496 - Cough Assist in Bronchiolitis N/A
Not yet recruiting NCT01414322 - Documentation of Continuous Wheeze and Cough Dynamics in Pediatric ER SOB Patients N/A
Completed NCT00369759 - An Epidemiological Study to Evaluate the RSV-Associated Lower Respiratory Track in Infections in Infants N/A
Completed NCT00347880 - Atrial and Brain Natriuretic Peptides in Bronchiolitis Phase 1
Recruiting NCT05548036 - A Feasibility RCT of Aerobika Verses ACBT in People With COPD N/A
Active, not recruiting NCT04302207 - The ROUTT-B (Reduce Over-Utilized Tests and Treatments in Bronchiolitis) Study N/A
Completed NCT02858531 - Predictive Tracking of Patient Flow in the Emergency Services During the Virus Winter Epidemics
Withdrawn NCT05994183 - The Bronchiolitis in Hospitalized Infants Study Early Phase 1
Terminated NCT03614507 - Automation Oxygen Flow Titration in Spontaneously Breathing Infants N/A
Completed NCT02856165 - High-flow Nasal Oxygen Therapy in Hospitalized Infant With Moderate-to-severe Bronchiolitis N/A
Recruiting NCT05909566 - Respiratory Support and Treatment for Efficient and Cost-Effective Care N/A
Recruiting NCT04437641 - Impact of Pediatrician Intervention on the Smoking Habits of Parents of Sick Children
Not yet recruiting NCT06083077 - Chest and Abdominal Wall Strapping in Infant With Bronchiolitis N/A